The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Contribution of the Major Copper Influx Transporter CTR1 to the Cellular Accumulation of Cisplatin, Carboplatin, and Oxaliplatin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162491399 · Cited by 927
Cellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
Self-citationEssential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development
Lee, J., Prohaska, J. R., & Thiele, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111058698 · Cited by 472
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.
Andrews, P. A., & Howell, S. B. (1990) · PubMed · Cited by 397
Self-citationThe copper transporter CTR1 provides an essential function in mammalian embryonic development
Kuo, Y.-M., Zhou, B., Cosco, D., & Gitschier, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111057298 · Cited by 396
Samimi, G., Safaei, R., Katano, K., Holzer, A. K., Rochdi, M., Tomioka, M., Goodman, M., & Howell, S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0137 · Cited by 358
Self-citationKatano, K., Kondo, A., Safaei, R., Holzer, A. K., Samimi, G., Mishima, M., Kuo, Y., Rochdi, M., & Howell, S. B. (2002) · PubMed · Cited by 291
Self-citationSong, I.-S., Savaraj, N., Siddik, Z. H., Liu, P., Wei, Y., Wu, C. J., & Kuo, M. T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1543.3.12 · Cited by 259
Holzer, A. K., Samimi, G., Katano, K., Naerdemann, W., Lin, X., Safaei, R., & Howell, S. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001198 · Cited by 245
Self-citationCharacterization of Mouse Embryonic Cells Deficient in the Ctr1 High Affinity Copper Transporter
Lee, J., Petris, M. J., & Thiele, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208002200 · Cited by 244
The Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae
Lin, X., Okuda, T., Holzer, A., & Howell, S. B. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1154 · Cited by 232
Self-citationSamimi, G., Katano, K., Holzer, A. K., Safaei, R., & Howell, S. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.25 · Cited by 158
Self-citationAndrews, P. A., Jones, J. A., Varki, N. M., & Howell, S. B. (1990) · Cancer Communications · doi:10.3727/095535490820874641 · Cited by 130
Self-citationThe SLC31 (Ctr) copper transporter family
Petris, M. J. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1092-1 · Cited by 123
The role of copper transporters in the development of resistance to Pt drugs
Safaei, R., Holzer, A. K., Katano, K., Samimi, G., & Howell, S. B. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.05.006 · Cited by 114
Self-citationRomach, E. H., Zhao, C. Q., Razo, L. M. D., Cebrián, M. E., & Waalkes, M. P. (2000) · Toxicological Sciences · doi:10.1093/toxsci/54.2.500 · Cited by 89
Cross-resistance to cisplatin in cells with acquired resistance to copper
Safaei, R., Katano, K., Samimi, G., Naerdemann, W., Stevenson, J. L., Rochdi, M., & Howell, S. B. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0736-3 · Cited by 72
Self-citation
Cited by
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
Molecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Shen, D.-W., Pouliot, L. M., Hall, M. D., & Gottesman, M. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005637 · Cited by 955
Metadata
- Authors
- Holzer, A. K., Manorek, G. H., & Howell, S. B.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 70
- Issue
- 4
- Pages
- 1390-1394
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2100506495
- Cited by
- 322
- References
- 18
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.